LANNETT TO PRESENT AT THE 34th ANNUAL ROTH CONFERENCE ON MARCH 14

Author's Avatar
Mar 04, 2022

--Company Announces Receipt of FDA Complete Response Letter (CRL) for Generic Advair Diskus® Product; Based on Preliminary Review, Company Expects At Least a Second Review Cycle--

PR Newswire